Scott Gottlieb: “There just is no link between the MMR vaccine and autism.”

the most important incentive to developing useful information remains the ability for companies to market drugs based on what has been proven scientifically.

I think we should start lifting these restrictions as aggressively as we put them in.

I found that most plans excluded 6 or 7 of the 12 top drugs that you use to treat the disease.

I see it as a strengthening, because we are going from a hard threshold of 30 percent to a risk-based threshold of 50 percent.